Feb 25, 2021 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Bayer's investor and analyst conference call on the full year and fourth quarter 2020 results. (Operator Instructions) I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead.
Oliver Maier - Bayer Aktiengesellschaft - Head of IR
Great. Thank you so much, Haley. Good afternoon, and thanks, everybody, for joining us today. I'd like to welcome all of you for our full year 2020 conference call.
With me on the call today are Werner Baumann, our CEO; and Wolfgang Nickl, our CFO. And as always, the businesses are represented by the responsible Management Board members. So we have Stefan Oelrich for Pharma. We have Liam Condon for Crop Science. And we have Heiko Schipper for Consumer Health.
Werner will begin today's call with an overview of the key developments, performance of the divisions and the strategic outlook, while Wolfgang will then cover the financials for the full year as well as the outlook for 2021 before we open
Q4 2020 Bayer AG Earnings Call Transcript
Feb 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers